UK Vaccines Business Pushes Wockhardt To Sales Growth

Company ‘Makes about 80% Of The AstraZeneca Vaccine’

 
• By Dean Rudge
  
COVID coronavirus impact graph recovery
Wockhardt reported a pre-tax loss despite its sales growth • Source: Alamy

More from Earnings

More from Business